Skip To Main Content
Panagiotis Bargiotas on Muck Rack

Panagiotis Bargiotas

As seen in: MDPI, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Panagiotis

Contact Panagiotis, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sleepiness and Vitamin D Levels in Patients with Obstructive Sleep Apnea

|
By Kostas Archontogeorgis, Nicholas-Tiberio Economou, Panagiotis Bargiotas, Evangelia Nena
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Sleepiness and Vitamin D Levels in Patients with Obstructive Sleep Apnea

|
By Kostas Archontogeorgis, Panagiotis Bargiotas, Evangelia Nena, Nicholas-Tiberio Economou
| Preprints.org
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 22 February 2024 / Approved: 26 February 2024 / Online: 26 February 2024 (13:57:15 CET) Archontogeorgis, K.; Economou, N.; Bargiotas, P.; Nena, E.; Voulgaris, A.; Chadia, K.; Trakada, G.; Romigi, A.; Steiropoulos, P. Sleepiness and Vitamin D Levels in Patients with Obstructive Sleep Apnea. Preprints 2024, 2024021448.
Open in Who Shared Issue with article?

Neurovascular adverse effects of sars-cov-2 vaccination

|
By Leonidas D Panos, Panagiotis Bargiotas, Georgios F. Hadjigeorgiou, Georgios D Panos
| Dove Medical Press
Introduction The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has been a defining global health crisis of our time.1 In response, the development and global deployment of COVID-19 vaccines have been pivotal in combating the spread of the virus. Representing a monumental achievement in the fields of medicine and biotechnology, these vaccines have been developed using various innovative platforms.
Open in Who Shared Issue with article?
See all 7 articles